LogicInk Corporation

LogicInk Corporation develops innovative biochemical wellbeing sensors that enhance personal health management through real-time tracking of wellness metrics, including UV exposure and hydration levels. LogicInk Corporation specializes in creating wearable biochemical sensors aimed at improving individual health awareness. Founded by Carlos Olguin, Marcelo Coelho, Skylar Tibbits, and Steven Wrobel, the company is headquartered in San Francisco, US. The most recent funding occurred in April 2017, when LogicInk raised seed funding from Breakout Labs, with one deal recorded to date.

LogicInk specializes in developing a range of biochemical wellbeing sensors designed for daily wear or application. The core products include sensors that monitor safe UV exposure, hydration levels, and genetic predispositions, along with ongoing development of concussion screening tools. These sensors provide real-time feedback, enabling users to track their health metrics conveniently. The target audience includes fitness enthusiasts, parents, and individuals with specific health concerns, with products marketed primarily in North America and Europe.

LogicInk’s revenue model is focused on direct-to-consumer sales of its wellbeing sensors, which may include subscription services for ongoing product support or updates. Customers purchase individual sensors through the company’s online platform, with potential tiered pricing for bundled sensor packages or subscription options. While specific pricing details are not disclosed, the direct sales approach positions LogicInk to leverage the growing interest in personalized health technology. Looking ahead, LogicInk plans to launch new products aimed at expanding their sensor offerings.

The company is also focused on entering new markets, specifically targeting additional regions within Europe and Asia by the end of 2023. The funds raised in April 2017 are expected to support these initiatives, including product development and market expansion strategies.